193 related articles for article (PubMed ID: 37047730)
1. The Impact of
Santos M; Lima L; Carvalho S; Mota-Pereira J; Pimentel P; Maia D; Correia D; Barroso MF; Gomes S; Cruz A; Medeiros R
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047730
[TBL] [Abstract][Full Text] [Related]
2. Gene-based analysis of genes related to neurotrophic pathway suggests association of BDNF and VEGFA with antidepressant treatment-response in depressed patients.
Kao CF; Liu YL; Yu YW; Yang AC; Lin E; Kuo PH; Tsai SJ
Sci Rep; 2018 May; 8(1):6983. PubMed ID: 29725086
[TBL] [Abstract][Full Text] [Related]
3. BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients.
Colle R; Deflesselle E; Martin S; David DJ; Hardy P; Taranu A; Falissard B; Verstuyft C; Corruble E
Pharmacogenomics; 2015; 16(9):997-1013. PubMed ID: 26122862
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Mendlewicz J; Noro M; Montgomery S; Oswald P; Snyder L; Zohar J; Souery D
Int Clin Psychopharmacol; 2011 Jan; 26(1):1-10. PubMed ID: 21188787
[TBL] [Abstract][Full Text] [Related]
5. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
[TBL] [Abstract][Full Text] [Related]
6. Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population.
Zhang K; Yang C; Xu Y; Sun N; Yang H; Liu J; Xu Q; Shen Y
J Neural Transm (Vienna); 2010 Mar; 117(3):393-401. PubMed ID: 20033742
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
Calati R; Crisafulli C; Balestri M; Serretti A; Spina E; Calabrò M; Sidoti A; Albani D; Massat I; Höfer P; Amital D; Juven-Wetzler A; Kasper S; Zohar J; Souery D; Montgomery S; Mendlewicz J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():271-8. PubMed ID: 23537502
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression.
Hennings JM; Kohli MA; Uhr M; Holsboer F; Ising M; Lucae S
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109686. PubMed ID: 31295515
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response.
Domschke K; Lawford B; Laje G; Berger K; Young R; Morris P; Deckert J; Arolt V; McMahon FJ; Baune BT
Int J Neuropsychopharmacol; 2010 Feb; 13(1):93-101. PubMed ID: 19236730
[TBL] [Abstract][Full Text] [Related]
10. Association between NTRK2 Polymorphisms, Hippocampal Volumes and Treatment Resistance in Major Depressive Disorder.
Paolini M; Fortaner-Uyà L; Lorenzi C; Spadini S; Maccario M; Zanardi R; Colombo C; Poletti S; Benedetti F
Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38002980
[TBL] [Abstract][Full Text] [Related]
11. BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression.
Murphy GM; Sarginson JE; Ryan HS; O'Hara R; Schatzberg AF; Lazzeroni LC
Pharmacogenet Genomics; 2013 Jun; 23(6):301-13. PubMed ID: 23619509
[TBL] [Abstract][Full Text] [Related]
12. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.
Perroud N; Aitchison KJ; Uher R; Smith R; Huezo-Diaz P; Marusic A; Maier W; Mors O; Placentino A; Henigsberg N; Rietschel M; Hauser J; Souery D; Kapelski P; Bonvicini C; Zobel A; Jorgensen L; Petrovic A; Kalember P; Schulze TG; Gupta B; Gray J; Lewis CM; Farmer AE; McGuffin P; Craig I
Neuropsychopharmacology; 2009 Nov; 34(12):2517-28. PubMed ID: 19641488
[TBL] [Abstract][Full Text] [Related]
13. No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.
Deflesselle E; Verstuyft C; Petit AC; Hardy P; David DJ; Falissard B; Fève B; Rigal L; Becquemont L; Corruble E; Colle R
Pharmacogenomics; 2017 Mar; 18(4):349-357. PubMed ID: 28244805
[TBL] [Abstract][Full Text] [Related]
14. PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel.
Pfisterer K; Fusi A; Klinghammer K; Knödler M; Nonnenmacher A; Keilholz U
Head Neck; 2015 Apr; 37(4):471-8. PubMed ID: 24421178
[TBL] [Abstract][Full Text] [Related]
15. Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach.
Hennings JM; Kohli MA; Czamara D; Giese M; Eckert A; Wolf C; Heck A; Domschke K; Arolt V; Baune BT; Horstmann S; Brückl T; Klengel T; Menke A; Müller-Myhsok B; Ising M; Uhr M; Lucae S
PLoS One; 2013; 8(6):e64947. PubMed ID: 23750220
[TBL] [Abstract][Full Text] [Related]
16. Investigating the associations between polymorphisms in the NTRK2 and NGFR genes and completed suicide in the Slovenian sample.
Ropret S; Zupanc T; Komel R; Videtič Paska A
Psychiatr Genet; 2015 Dec; 25(6):241-8. PubMed ID: 26462037
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.
Xu JL; Wang ZW; Hu LM; Yin ZQ; Huang MD; Hu ZB; Shen HB; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(5):2157-62. PubMed ID: 22901187
[TBL] [Abstract][Full Text] [Related]
18. HOMA-IR increase after antidepressant treatment in depressed patients with the Met allele of the Val66Met BDNF genetic polymorphism.
Martin S; Colle R; El Asmar K; Rigal A; Vievard A; Feve B; Becquemont L; Verstuyft C; Corruble E
Psychol Med; 2019 Oct; 49(14):2364-2369. PubMed ID: 30526722
[TBL] [Abstract][Full Text] [Related]
19. The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice.
Li Z; Zhang Y; Wang Z; Chen J; Fan J; Guan Y; Zhang C; Yuan C; Hong W; Wang Y; Wu Z; Huang J; Hu Y; Cao L; Yi Z; Cui D; Yu S; Fang Y
J Psychiatr Res; 2013 Jan; 47(1):8-14. PubMed ID: 23137999
[TBL] [Abstract][Full Text] [Related]
20. Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study.
Chen MH; Kao CF; Tsai SJ; Li CT; Lin WC; Hong CJ; Bai YM; Tu PC; Su TP
Genomics; 2021 Mar; 113(2):507-514. PubMed ID: 33370585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
